Skip to main content

Table 3 Repeated measures ANOVA

From: Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor

 

Glucose before

Glucose after 1 month

Glucose after 6 months

Mauchly’s sphericity test

Greenhouse-Geisser p value

Subjects with fasting glucose < 100 mg/dL (n = 76)

87.6 ± 8.3

93.6 ± 7.6

93.4 ± 10.5

0.960

0.048

Subjects with fasting glucose ≥100 mg/dL (n = 19)

121 ± 28.7

97. 3 ± 12.8

96. 1 ± 7.3

0.184

0.076

Subjects with T2DM (n = 11)

241 ± 120.7

152.5 ± 74.5

128.6 ± 33.9

0.702

0.042

  1. Database was analyzed through the ANOVA test of repeated samples to determine the statistical significance between normal FG, IFG and T2DM subjects before treatment and at 1 and 6 months follow-up. The Mauchly’s sphericity test was used to evaluate equality and homogeneity of the studied population, and the p value was obtained through the Greenhouse-Geisser test